Comparson of the immunogenicity of genotypeⅠJapanese encephalitis virus subunit vaccine candidate antigens.
- Author:
Ruiming YU
1
;
Zhancheng TIAN
1
;
Shandian GAO
1
;
Junzheng DU
1
;
Guangyuan LIU
1
;
Jianxun LUO
1
;
Hong YIN
1
Author Information
- Publication Type:Journal Article
- Keywords: Japanese encephalitis; immunogenicity; polytope; subunit vaccine
- MeSH: Animals; Antibodies, Viral; blood; Antigens, Viral; immunology; Encephalitis Virus, Japanese; immunology; Encephalitis, Japanese; immunology; prevention & control; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Vaccines, Subunit; immunology; Viral Vaccines; immunology
- From: Chinese Journal of Biotechnology 2020;36(7):1314-1322
- CountryChina
- Language:Chinese
- Abstract: To screen the best genotypeⅠJapanese encephalitis virus subunit vaccine candidate antigens, the prMEIII gene, the polytope gene and the prMEIII-polytope fusion gene of the GenotypeⅠJapanese encephalitis virus GS strain were cloned into prokaryotic expression vector pET-30a. The recombinant proteins were obtained after the induction and purification. The prepared recombinant proteins were immunized to mice, and the immunogenicity of the subunit vaccine candidate antigens was evaluated through monitoring the humoral immune response by ELISA, detecting the neutralizing antibody titer by plaque reduction neutralization test, and testing the cell-mediated immune response by lymphocyte proliferation assay and cytokine profiling. The recombinant proteins with the molecular weights of 35 (prMEIII), 28 (polytope antigen) and 57 kDa (prMEIII-polytope) induced strong humoral and cellular immune responses in mice. Compared with prMEIII-polytope and polytope proteins, the prMEIII protein induced a significant expression of IL-2 and IFN-γ (P<0.05) and the significant lymphoproliferation of splenocytes (P<0.05). The neutralizing antibody titer induced by the prMEIII protein was close to that induced by the commercial attenuated vaccine SA14-14-2 (P>0.05). The study suggests that the prMEIII protein can be used for the development of the Japanese encephalitis virus subunit vaccine.
